Similarly, mutations in the NOTCH1 pathway correlate with shorter overall survival and increased risk of histologic transformation, particularly in CLL, MCL, and splenic marginal zone lymphoma (SMZL). The gene discussed is NOTCH1; the disease is splenic marginal zone lymphoma.